Withholding or continuing glucose-lowering drugs for elective surgery in patients with type 2 diabetes mellitus: a secondary analysis of the MOPED international, prospective, observational study - Pub
4 hours ago
- #metformin
- #diabetes management
- #perioperative care
- The study tested if continuing glucose-lowering drugs before surgery affects days alive at home out of hospital at 30 days (DAH-30) in type 2 diabetes patients.
- Continuing metformin on surgery day was associated with a small increase in DAH-30 (0.47 days), but the effect was marginal.
- No significant association was found between stopping or continuing SGLT2i or GLP-1 RA drugs and DAH-30 outcomes.
- The sample sizes for SGLT2i and GLP-1 RA groups were too small to draw meaningful conclusions about their impact.